Abstract
Background
The severe acute respiratory syndrome (SARS) coronavirus-2 is a novel
coronavirus belonging to the family Coronaviridae and is now known to be
responsible for the outbreak of a series of recent acute atypical respiratory
infections originating in Wuhan, China. The disease caused by this virus,
termed coronavirus disease 19 or simply COVID-19, has rapidly spread throughout
the world at an alarming pace and has been declared a pandemic by the WHO on
March 11, 2020. In this review, an update on the pathophysiology, clinical
presentation and the most recent management strategies for COVID-19 has been
described.
Materials and Methods
A search was conducted for literature and various articles/case reports
from 1997 to 2020 in PUBMED/MEDLINE for the keywords coronavirus, SARS, Middle
East respiratory syndrome and mRNA virus.
Results and Conclusions
COVID-19 has now spread globally with increasing morbidity and mortality
among all populations. In the absence of a proper and effective antibody test,
the diagnosis is presently based on a reverse-transcription PCR of
nasopharyngeal and oropharyngeal swab samples. The clinical spectrum of the
disease presents in the form of a mild, moderate or severe illness. Most
patients are either asymptomatic carriers who despite being without symptoms
have the potential to be infectious to others coming in close contact, or have
a mild influenza-like illness which cannot be differentiated from a simple
upper respiratory tract infection. Moderate and severe cases require
hospitalisation as well as intensive therapy which includes non-invasive as
well as invasive ventilation, along with antipyretics, antivirals, antibiotics
and steroids. Complicated cases may require treatment by immunomodulatory drugs
and plasma exchange therapy. The search for an effective vaccine for COVID-19
is presently in full swing, with pharmaceutical corporations having started
human trials in many countries.
Cited by
505 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献